Esperion Therapeutics
ESPR
#7554
Rank
NZ$0.54 B
Marketcap
$2.78
Share price
-4.49%
Change (1 day)
-19.23%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of March 2025 (TTM): 0.9853

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.8845. At the end of 2024 the company had a P/S ratio of 1.35.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.56 566.09%๐Ÿ‡บ๐Ÿ‡ธ USA
4.80 387.24%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33 136.43%๐Ÿ‡บ๐Ÿ‡ธ USA
5.15 422.67%๐Ÿ‡บ๐Ÿ‡ธ USA
5.30 438.29%๐Ÿ‡บ๐Ÿ‡ธ USA
4.04 310.42%๐Ÿ‡บ๐Ÿ‡ธ USA